Selected Papers from the 46th EuroCongress on Drug Synthesis and Analysis (ECDSA-2017)
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 September 2017) | Viewed by 130677
Special Issue Editors
Interests: molecular medicine; digital health; open innovation; biotechnology; natural products; science communication; molecular pharmacology
Special Issues, Collections and Topics in MDPI journals
2. Department of Chemical Biology, Faculty of Science, Palacky University, Olomouc, Slechtitelu 27, 78371 Olomouc, Czech Republic
Interests: medicinal chemistry; drug design; structure–activity relationships; pharmaceutical analysis; polymorphism; drug bioavailability; ADME; nanoparticles; nanoformulations; controlled/targeted delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The 46th EuroCongress on Drug Synthesis and Analysis (ECDSA-2017) will be arranged within the celebration of the 65th Anniversary of the Faculty of Pharmacy at Comenius University in Bratislava, Slovakia. The congress will be held at the Faculty of Pharmacy in Bratislava, Slovakia on September 5–8, 2017.
The traditional symposium “Drug Synthesis and Analysis” has a long history. Over the last decade it has been transformed from a local Czech-Slovak symposium to an international conference, and now this prestigious international conference has become known as “EuroCongress on Drug Synthesis and Analysis“. These high-quality series of meetings cover all the fields of pharmaceutical sciences. The aim of ECDSA is to develop a platform for promoting cooperation between scientists sharing scientific interests in pharmaceutical/biomedical sciences from European and other countries and to support cooperation between scientists in this field. Excellent speakers from all over the world will present their results within individual sections of ECDSA-2017. For all details please see https://sites.google.com/site/cfph2017, where the full list of presenters is available, including Danica Agbaba, Marc Diederich, Norbert Haider, Yifan Han, Danijel Kikelj, Teresa Kowalska, Mark Olsen, Wei-Dong Pan, András Perczel, Robert C. Reynolds, Jerzy Silberring, Christian H. Zidorn and many others.
Participants of the conference are cordially invited to contribute original research papers or reviews to this Special Issue of Molecules.
Prof. Dr. Atanas G. Atanasov, Ph.D.
Prof. Dr. Josef Jampilek, Ph.D.
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Drug design, research and development
- Drug formulations and drug delivery systems
- Structure, function and interactions of proteins
- Natural compounds
- Structural analysis
- Solid state analysis
- Electrochemistry
- Chiral compounds
- Chemical biology
- Biological chemistry
- Engineered enzymes
- Nucleic acids chemistry
- Targeting
- Biomaterials
- Nanomaterials
- Pharmacology and ADME
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.